Chemical Structure : (R)-BA-1049
Catalog No.: PC-20084Not For Human Use, Lab Use Only.
(R)-BA-1049 (NRL-1049) is a potent, orally-available ROCK2-selective inhibitor with IC50 of 0.24 uM, 16-fold selectivity over ROCK-1.
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
(R)-BA-1049 (NRL-1049) is a potent, orally-available ROCK2-selective inhibitor with IC50 of 0.24 uM, 16-fold selectivity over ROCK-1.
Neither BA-1049 nor the metabolite inhibits PKA or PKC at physiological ATP concentrations.
BA-1049 is a promising drug candidate to reduce lesion growth and hemorrhage in both CCM1 and CCM3 models of cavernous angioma (CA).
M.Wt | 319.42 | |
Formula | C16H21N3O2S | |
Appearance | Solid | |
Storage |
|
|
Solubility |
10 mM in DMSO |
1. Lisa McKerracher, et al. Transl Stroke Res. 2020 Jun;11(3):365-376.
2. Patent US20170313680A1.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright